TrialPain medicine (Malden, Mass.)2020

A Multicenter, Prospective, Randomized, Placebo-Controlled, Double-Blind Study of a Novel Pain Management Device, AT-02, in Patients with Fibromyalgia.

Hiroshi Oka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.